Triglav Skladi’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.4M Sell
84,162
-29,356
-26% -$6.84M 1.13% 23
2026
Q1
$27.7M Buy
113,518
+32,700
+40% +$7.62M 1.94% 16
2025
Q4
$16.7M Sell
80,818
-1,982
-2% -$392K 1.06% 21
2025
Q3
$15.4M Buy
82,800
+21,900
+36% +$3.75M 1% 23
2025
Q2
$9.3M Sell
60,900
-1,600
-3% -$246K 0.67% 31
2025
Q1
$10.4M Buy
62,500
+3,000
+5% +$469K 0.87% 29
2024
Q4
$8.6M Buy
+59,500
New +$9.22M 0.68% 34

Other funds holding JNJ

Triglav Skladi's JNJ Position: Q2 2026 in Review

Triglav Skladi reduced its Johnson & Johnson (JNJ) stake by 26% in Q2 2026, selling an estimated $6.84M and leaving 84,162 shares worth $21.4M. The position accounts for 1.13% of the portfolio, ranked #23.

Triglav Skladi first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $27.7M in Q1 2026. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Triglav Skladi held 84,162 shares of Johnson & Johnson worth $21.4M as of Q2 2026.
  • Triglav Skladi sold 29,356 Johnson & Johnson shares in Q2 2026, an estimated $6.84M.
  • Johnson & Johnson made up 1.13% of Triglav Skladi's portfolio in Q2 2026, its #23 holding.
  • Triglav Skladi first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • Triglav Skladi's Johnson & Johnson position peaked at $27.7M in Q1 2026.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Triglav Skladi's 13F filing for Q2 2026, filed 11 Aug 2026.